Ordering
Available Variants50 mg
CHA.20835-50mg
Price
€433.60
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.20835-50mg | €433.60 |
pharmaceutical impurity standard
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Linear Formula | CH3OC10H6CH(CH3)CO2H |
|---|---|
| CAS Number | 23979-41-1 |
| Molecular Weight | 230.26 |
| NACRES | NA.24 |
| PubChem Substance ID | 329769238 |
| UNSPSC Code | 41116107 |
| EC Number | 245-966-6 |
| MDL number | MFCD00870716 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302 |
| pcodes | P301 + P312 + P330 |
| Hazard Classifications | Acute Tox. 4 Oral |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
(R)-Naproxen, with a CAS number of 23979-41-1, is a nonsteroidal anti-inflammatory drug (NSAID) that exhibits high enantioselectivity, meaning its therapeutic effects are predominantly associated with the (R)-enantiomer. This compound is a potent inhibitor of cyclooxygenase enzymes, which are involved in the synthesis of prostaglandins, key mediators of inflammation and pain. As a result, (R)-Naproxen is effective in reducing inflammation, relieving pain, and lowering fever. It is commonly used to treat various conditions, including rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. The (R)-enantiomer is the active form of naproxen, and its use can help minimize adverse effects associated with the (S)-enantiomer, which has been shown to be less active and potentially more toxic. Overall, (R)-Naproxen is a valuable therapeutic agent for the management of inflammatory disorders.
